Australia’s Healthscope prepares for potential sale after securing lender relief

Published 03/11/2025, 02:24 AM
© Reuters.

Investing.com-- Brookfield-owned Healthscope, Australia’s second-largest private hospital operator, has initiated preparations for a potential sale after securing temporary relief from its lenders amid financial challenges, local media reports stated on Tuesday.

The company has entered into short-term forbearance arrangements with the majority of its senior lenders, allowing it until May to explore long-term solutions, including a possible sale, to address its $1.6 billion debt, the reports said.

As part of the forbearance agreements, it will begin preparing for a possible sale of the business while also engaging in wider restructuring discussions with key stakeholders, the Australian Financial Review reported citing a company statement.

Healthscope, owned by Brookfield since a $4.4 billion acquisition in 2019, has faced mounting debts exacerbated by rising medical costs and challenges in securing higher reimbursements from health insurers, The Australian reported.

These financial strains have led to missed rent payments and heightened concerns about the company’s viability, The Australian’s report added.

Potential buyers, including HMC Capital, are reportedly considering acquiring Healthscope, though no formal offers have been made, the reports said.

The outcome of these developments will significantly impact Australia’s healthcare landscape, with stakeholders closely monitoring the situation.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.